...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR virtual meeting June22nd

Thx for correction Bear.Does this mean it is another trial or just lab work in addition to the breast trial?

Share
New Message
Please login to post a reply